Reckitt Benckiser to buy Paras Pharma for $726 million
New York/Mumbai: British consumer goods firm Reckitt Benckiser agreed to buy privately-held Indian company Paras Pharmaceuticals for about $726 million, to boost its operations in a fast-growing healthcare market.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.